La vendita allo scoperto per BNY Mellon Innovators ETF dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di BNY Mellon Innovators ETF. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

BNY Mellon Innovators ETF (NASDAQ:BKIV), Report sulle vendite allo scoperto

Technology

Healthcare

Consumer Cyclical

Communication Services

Consumer Defensive

Real Estate

Energy

To pursue its goal, the fund normally invests principally in equity securities of U.S. innovation-driven companies. The fund's sub-adviser, Newton Investment Management North America, LLC (NIMNA), an affiliate of the Adviser, considers innovation-driven companies to be (i) leading edge companies that, through their intellectual property, provide ground-breaking or innovative products and services that can be disruptive and transformative to existing business models and practices and (ii) business enterprises that are positively impacted by the transformation of their business models and practices through the use of such products or services.

Nvidia Corp.

Alphabet Inc., Class C

Insmed Inc

Costar Group Inc.

Repligen Inc.

Netflix Inc.

Inspire Med Sys Inc

Align Technology Inc.

Celsius Holdings Inc Common Stock USD 0.001

Freshpet Inc.

Klaviyo Inc

Confluent, Inc.

Irhythm Technologies Inc.

Shopify Inc Class A

BNY Mellon Innovators ETF

Keybanc analyst Steve Barger downgrades Teradyne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) from Overweight to Sector Weight.

News

Downgrades

Analyst Ratings

Keybanc Downgrades Teradyne to Sector Weight

U.S. Customs and Border Protection (CBP) has reported tariff revenue of just over $500 million after the implementation of President Donald Trump's latest trade measures.
This is far below the $2 billion per day figure Trump has often cited while presenting his case for his <a href="https://www.benzinga.com/news/25/04/44857178/trump-joins-japan-tariff-talks-calls-progress-big-as-63-billion-trade-surplus-looms">tariff policies</a>.
The updated numbers come as <a href="https://www.benzinga.com/25/04/44843002/analysts-who-predicted-trump-tariffs-says-were-headed-for-worse-financial-crisis-than-2008-its-probably-too-late">China's total tariffs</a> include a 125% reciprocal duty, an additional 20% connected with the fentanyl crisis, and targeted <a href="https://www.benzinga.com/markets/25/04/44831287/trump-administration-imposes-up-to-245-tariff-on-chinese-imports-amid-intensifying-trade-battle">levies ranging from 7.5% to 100% on specific goods</a>, according to the latest reports from the White House.
What Happened: CBP shared <a href="https://www.cnbc.com/2025/04/16/us-customs-tariffs-revenue-generated-since-april-5.html">with</a> CNBC that since April 5, the agency has collected more than $500 million from the newly imposed reciprocal tariffs, which are part of a larger series of trade actions enacted since January 20.
"Even during the brief glitch," CBP said, referring to a recent 10-hour system outage that impacted exemption codes for certain in-transit goods, "CBP's average $250 million/day revenue stream remained uninterrupted."
See Also: <a href="https://www.benzinga.com/25/04/44837814/christmas-is-at-risk-toy-industry-ceo-warns-trumps-china-tariffs-threaten-holiday-season">&#8216;Christmas Is At Risk:&#8217; Toy Industry CEO Warns Trump&#8217;s Tariffs Could Derail Holiday Season</a>
Why It Matters: Trump has repeatedly said that the U.S. is generating $2 billion a day through tariffs. However, the latest figures indicate that revenue is much lower. Treasury Department data released Monday reports total daily deposits from customs and excise taxes at $305 million.
The CBP collects all tariffs at the point of entry. The <a href="https://www.benzinga.com/markets/25/04/44857255/california-becomes-the-first-state-to-sue-trump-over-unlawful-tariff-regime-seeking-to-declare-it-null-and-void-global-trade-policy-is-not-just-a-game">discrepancy between Trump's claims</a> and the actual data raises questions about the financial benefits of the tariffs, which have witnessed fluctuating rates across sectors and countries, and a sustained increase on Chinese goods.
While the administration pushes forward with its <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44848474/fed-chair-powell-says-tariffs-lead-to-temporary-rise-in-inflation">tariff-centered trade approach</a>, the gap between public claims and official revenue data is increasingly generating attention. With new policies for industries like pharmaceuticals on the horizon, the conversation over the costs and benefits of Trump's tariff agenda is likely to continue.
Read Next:
<ul>
<li><a style="font-weight: bold;" href="https://www.benzinga.com/news/25/04/44835297/crypto-czar-david-sacks-says-trump-was-right-about-this-as-he-slams-washingtons-bipartisan-consensus-on-unfettered-free-trade">Crypto Czar David Sacks Says Trump Was &#8216;Right About This&#8217; As He Slams Washington&#8217;s Bipartisan Consensus On &#8216;Unfettered Free Trade&#8217;</a></li>
</ul>
Image via Shutterstock

General

CBP's Latest Tariff Figures Reveal $500 Million In Collections, Dwarfing Trump's $2 Billion Daily Estimate

Keybanc analyst Steve Barger downgrades Amkor Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) from Overweight to Sector Weight.

AMKR

Keybanc Downgrades Amkor Tech to Sector Weight

WIIM

Eli Lilly shares are trading higher after the company announced topline Phase 3 results from its ACHIEVE-1 trial, which showed orforglipron demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines.

Keybanc analyst Jackson Ader downgrades Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) from Overweight to Sector Weight.

MSFT

Keybanc Downgrades Microsoft to Sector Weight

THE WOODLANDS, Texas, April 17, 2025 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REI#NYSE">REI</a>) ("Ring" or the "Company") today provided an operational update, including first quarter 2025 oil sales volumes above the high end of the Company's guidance range and total sales volumes above the midpoint of guidance. The Company also announced the timing of Ring's quarterly results conference call.
KEY HIGHLIGHTS
<ul>
<li>Produced over 12,000 barrels of oil per day ("Bo/d"), exceeding high end of guidance;</li>
<li>Produced over 18,300 barrels of oil equivalent per day ("Boe/d"), exceeding the midpoint of guidance;</li>
<li>Oil production outperformance was driven by the success of Ring's drilling program, featuring 7 horizontal and 3 vertical wells coming online, all surpassing the Company's pre-drill estimates;</li>
<li>Completed the acquisition of the Central Basin Platform ("CBP") assets of Lime Rock Resources IV, LP ("Lime Rock") on March 31, 2025;
<ul>
<li>Highly accretive transaction provides immediate and meaningful increased cash flow from shallow declining, long life, oil weighted assets;</li>
<li>Realized initial operational synergies by reducing LOE over 5%;</li>
<li>Production during the first two weeks of Ring's operations exceeded expectations by over 200 Boe/d, averaging over 2,500 Boe/d; and</li>
</ul>
</li>
<li>Company has over 6,300 barrels of oil per day hedged with weighted average downside protection of $64.44 per barrel for the remainder of the year, as of April 1, 2025.</li>
</ul>

Ring Energy Produces Over 18,300 Boe/d, Exceeding Midpoint Of Guidance; Produces Over 12,000 Bo/d, Exceeding High End Of Guidance

<ul>
<li>Orforglipron is the first small molecule GLP-1 to successfully complete a Phase 3 trial, lowering A1C by an average of 1.3% to 1.6% across doses</li>
<li>The investigational once-daily oral pill reduced weight by an average 16.0 lbs (7.9%) at the highest dose in a key secondary endpoint</li>
<li>The overall safety and tolerability profile of&nbsp;orforglipron in ACHIEVE-1 was consistent with injectable GLP-1 therapies &nbsp;</li>
</ul>

Biotech

Large Cap

Health Care

Eli Lilly Announced Topline Phase 3 Results From ACHIEVE-1, Evaluating The Safety And Efficacy Of Orforglipron Compared To Placebo In Adults With Type 2 Diabetes And Inadequate Glycemic Control With Diet And Exercise Alone

Alcoa shares are trading lower after the company reported mixed Q1 results and reported a $20 million in additional costs during the quarter, stemming from newly imposed tariffs on Canadian aluminum imports.

HC Wainwright &amp; Co. analyst Yi Chen maintains Oculis Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCS#NASDAQ">OCS</a>) with a Buy and raises the price target from $29 to $32.

Price Target

HC Wainwright & Co. Maintains Buy on Oculis Holding, Raises Price Target to $32

D.R. Horton shares are trading lower after the company reported worse-than-expected Q2 results and lowered its FY25 guidance.

1Q 2025 Financial Update
FIS expects to report first quarter 2025 financial results on May 6, 2025. At this time, the Company is providing certain preliminary unaudited financial results and metrics for the three months ended March 31, 2025, based on currently available information.
<ul>
<li>Total company revenue of $2.5 billion, with adjusted revenue growth and recurring revenue growth of approximately 4%</li>
<li>Banking adjusted revenue growth of approximately 2%, which was above the high-end of the outlook; recurring revenue grew approximately 3%</li>
<li>Capital Markets adjusted revenue growth of approximately 9%, which was also above the high-end of the outlook; recurring revenue growth was approximately 6%</li>
<li>Adjusted EBITDA of approximately $958 million, toward the high-end of our outlook</li>
<li>Adjusted EPS of approximately $1.21, which was also toward the high-end of our outlook</li>
</ul>
The Company is reaffirming its prior full year 2025 outlook for Adjusted Revenue Growth, Adjusted EBITDA and Adjusted EPS.

FIS Expects Q1 Total Company Revenue Of $2.5B, With Adj. Revenue Growth And Recurring Revenue Growth Of About 4%; Reaffirms FY25 Outlook

Fifth Third Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FITB#NASDAQ">FITB</a>) reported quarterly earnings of $0.73 per share which beat the analyst consensus estimate of $0.70 by 4.29 percent. This is a 3.95 percent decrease over earnings of $0.76 per share from the same period last year. The company reported quarterly sales of $2.14 billion which missed the analyst consensus estimate of $2.16 billion by 1.11 percent. This is a 1.71 percent increase over sales of $2.10 billion the same period last year.

Earnings

Earnings Beats

Earnings Misses

FITB

Fifth Third Bancorp Q1 Adj EPS $0.73 Beats $0.70 Estimate, Sales $2.14B Miss $2.16B Estimate

ALHC

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

Shares of health insurance stocks are trading lower in sympathy with UnitedHealth, which reported worse-than-expected Q1 results and cut its FY25 adjusted EPS guidance below estimates.

UnitedHealth shares are trading lower after the company reported worse-than-expected Q1 results and cut its FY25 adjusted EPS guidance below estimates.

HC Wainwright &amp; Co. analyst Heiko Ihle reiterates Avino Silver &amp; Gold Mines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ASM#AMEX">ASM</a>) with a Buy and maintains $2.2 price target.

Reiteration

HC Wainwright & Co. Reiterates Buy on Avino Silver & Gold Mines, Maintains $2.2 Price Target

Sale of Industry-Leading Payments Technology and Solutions Company Marks an Important Milestone in&nbsp;GTCR's Strategic Transformation in Partnership with Leaders Strategy&#x2122;&nbsp;CEO Charles Drucker
CHICAGO, April 17, 2025 /PRNewswire/ --&nbsp;GTCR, a leading private equity firm, announced today the signing of a definitive agreement to sell Worldpay (the "Company"), a global leader in merchant acquiring and payments processing, to Global Payments (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPN#NYSE">GPN</a>) for $24.25 billion as part of a transformative three-way transaction.
In July 2023, GTCR signed a definitive agreement to acquire a 55% majority stake in Worldpay from FIS&#xAE; (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIS#NYSE">FIS</a>), a global leader in financial services technology. FIS retained the remaining 45% as part of the transaction. Under the terms of the sale agreement, Global Payments will acquire Worldpay from GTCR and FIS for $24.25 billion of cash and stock, while FIS will acquire Global Payments' Issuer Solutions business, at an enterprise value of $13.5 billion. As part of the Worldpay transaction, GTCR will receive 59% cash and 41% stock consideration and will continue to support the combined business through a successful integration and future growth. Upon closing, GTCR will own shares representing 15% of Global Payments' outstanding shares.
GTCR partnered with industry-veteran CEO Charles Drucker to acquire a majority stake in Worldpay from FIS in July 2023 behind a thesis of re-accelerating growth, affecting a seamless transition from FIS, and investing in innovative product and modern technology. Mr. Drucker&nbsp;assembled a world-class management team and executed a strategic vision centered on technology investments, operational improvements, and targeted acquisitions. Under Mr. Drucker's leadership, Worldpay expanded its global processing capabilities, launched innovative payment solutions, and enhanced its fraud prevention offerings. These initiatives supported new client wins, accelerated organic growth, and strengthened Worldpay's position as a leader in the global payments ecosystem.
The sale of Worldpay is expected to close in the first half of 2026, subject to regulatory approvals and customary closing conditions. The sale of Worldpay and the sale of Global Payments' Issuer Solutions business are cross-conditioned upon one another and will close at the same time.
&nbsp;

GTCR Agrees To Sell Worldpay To Global Payments For $24.25B As Part Of Transformative Three-way Transaction

Hertz Global shares are trading higher after Pershing Square Capital Management disclosed a stake via a 13F. CNBC reported that Pershing Square's stake is 19.8%, through shares & swaps.

HC Wainwright &amp; Co. analyst Amit Dayal maintains ClearSign Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIR#NASDAQ">CLIR</a>) with a Buy and lowers the price target from $6 to $2.

CLIR

HC Wainwright & Co. Maintains Buy on ClearSign Technologies, Lowers Price Target to $2

Guidance Based on the Company's results for the first half of the fiscal 2025 and current market conditions, D.R. Horton is updating its guidance for fiscal 2025 as follows:
<ul>
<li>Consolidated revenues in the range of $33.3 billion to $34.8 billion</li>
<li>Homes closed by homebuilding operations of 85,000 homes to 87,000 homes</li>
<li>Consolidated cash flow provided by operations of greater than $3.0 billion</li>
<li>Share repurchases of approximately $4.0 billion</li>
</ul>

Guidance

D.R. Horton Revised FY25 Guidance For Revenue To $33.3B-$34.8B (From $36B-$37.5B) Vs $36.4B Est., Homes Closed By Homebuilding Operations To 85,000-87,000 Homes (From 90,000-92,000 Homes)

Commodities

Markets

Westwater Resources Announced That It Is Experiencing Increased Demand For Its Natural Graphite Anode Material That Will Be Produced From Its Kellyton Graphite Plant After The Implementation Of Global Tariffs

Comments

BNY Mellon Innovators ETF

Vendite allo scoperto

BNY Mellon Innovators ETF (NASDAQ:BKIV), Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO